Holen Sie sich die Stockscreener-App
67.45
1.24%
-0.91
Schlusskurs vom Vortag:
$68.36
Offen:
$69.81
24-Stunden-Volumen:
777.90K
Relative Volume:
0.15
Marktkapitalisierung:
$12.01B
Einnahmen:
$803.32M
Nettoeinkommen (Verlust:
$-709.10M
KGV:
-8.6471
EPS:
-7.8003
Netto-Cashflow:
$-212.68M
1W Leistung:
+8.26%
1M Leistung:
-11.03%
6M Leistung:
+15.58%
1J Leistung:
+80.08%
1-Tages-Spanne:
$66.80
$69.88
1-Wochen-Bereich:
$63.02
$71.21
52-Wochen-Spanne:
$31.36
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Firmenname
Tempus Ai Inc
Sektor
Branche
Telefon
800-976-5448
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Vergleichen Sie TEM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
67.51 | 12.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
VEEV
Veeva Systems Inc
|
240.96 | 39.64B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
DOCS
Doximity Inc
|
43.65 | 8.23B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.17 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.92 | 7.05B | 11.99B | 24.18M | 234.31M | 0.2956 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-09-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-21 | Eingeleitet | BTIG Research | Buy |
| 2025-02-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Fortgesetzt | TD Cowen | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-09 | Eingeleitet | Guggenheim | Buy |
| 2024-11-11 | Herabstufung | Stifel | Buy → Hold |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-12 | Eingeleitet | Piper Sandler | Neutral |
| 2024-07-09 | Eingeleitet | BofA Securities | Buy |
| 2024-07-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-07-09 | Eingeleitet | Longbow | Buy |
| 2024-07-09 | Eingeleitet | Loop Capital | Buy |
| 2024-07-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-07-09 | Eingeleitet | Needham | Buy |
| 2024-07-09 | Eingeleitet | Stifel | Buy |
| 2024-07-09 | Eingeleitet | TD Cowen | Buy |
| 2024-07-09 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Tempus AI Stock Surges 82.4% in a Year: What's Driving It? - Zacks Investment Research
How Tempus AI Inc. stock performs in weak economyTrade Exit Report & AI Optimized Trade Strategies - ulpravda.ru
Does Tempus AI Inc. stock trade at a discount to peersRate Cut & AI Forecast Swing Trade Picks - ulpravda.ru
Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium - BioSpace
How Tempus AI Inc. stock reacts to oil prices2025 Price Momentum & Smart Investment Allocation Insights - ulpravda.ru
Should I hold or sell Tempus AI Inc. stock in 2025Quarterly Trade Review & Daily Technical Forecast Reports - ulpravda.ru
Is Tempus AI Inc. stock supported by innovation pipelineJuly 2025 EndofMonth & Low Drawdown Investment Ideas - ulpravda.ru
Is Tempus AI Inc. stock a defensive play in 2025July 2025 Final Week & Short-Term Trading Opportunity Alerts - ulpravda.ru
Why Tempus AI Inc. stock remains on buy lists2025 Stock Rankings & Momentum Based Trading Ideas - ulpravda.ru
Tempus to present eight research abstracts at ASCO GI symposium By Investing.com - Investing.com India
Published on: 2026-01-08 21:03:13 - ulpravda.ru
Tempus to present eight research abstracts at ASCO GI symposium - Investing.com
Rune Labs Taps Tempus Exec as New CEO to Expand AI-Enabled Neurology Care - The Joplin Globe
Ryan Fukushima Sells 5,000 Shares of Tempus AI (NASDAQ:TEM) Stock - MarketBeat
Fukushima, Tempus AI COO, sells $321k in shares By Investing.com - Investing.com India
Fukushima, Tempus AI COO, sells $321k in shares - Investing.com
Does Tempus AI’s (TEM) Insider Selling Undercut Ark’s Bullish Options-Driven Investment Narrative? - Yahoo Finance
Is Tempus AI Inc. stock in correction or buying zoneEarnings Per Share Trends & Free Gain Edge With Data - ulpravda.ru
Is Tempus AI (TEM) Stock Price Reflecting Its Rapid 1‑Year Surge? - simplywall.st
Cathie Wood Invests Millions in Tempus AI and George Soros-Backed Autonomous Firm After Major Announcement - inkl
Tempus AI stock slips premarket after 7.5% jump as JPM Healthcare Conference nears - TechStock²
Tempus AI (TEM) Valuation Checked As FDA Pathway Shift And Options Activity Draw Market Attention - Yahoo Finance
TEM's Stable Solvency and Financial Strength Are Gaining Attention - Nasdaq
Earnings Report: How Tempus AI Inc stock reacts to oil pricesJuly 2025 Sentiment & Precise Swing Trade Alerts - moha.gov.vn
Promising Artificial Intelligence Stocks To Follow TodayJanuary 4th - MarketBeat
Insider Sell: Jennifer Doudna Sells Shares of Tempus AI Inc (TEM) - GuruFocus
Best Artificial Intelligence Stocks To Watch NowJanuary 6th - MarketBeat
Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals - MSN
This AI Health Stock is Up Over 150% This Year—and It’s Not Slowing Down - AOL.com
Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference - BioSpace
AI in Oncology Market to Reach US$ 22.85 Billion by 2033 at 25.3% - openPR.com
cathie wood’s ARK sells roku stock, buys tempus AI and kodiak AI - Investing.com
Top Artificial Intelligence Stocks To Watch TodayJanuary 3rd - MarketBeat
Cathie Wood Loads Up On Tempus AI And This George Soros-Backed Company's Stock, Dumps Roku And Shopify SharesTempus AI (NASDAQ:TEM) - Benzinga
How Investors May Respond To Tempus AI (TEM) Pursuing FDA Pathways For Its AI-Driven Tests - simplywall.st
Tempus AI's Options Frenzy: What You Need to Know - Benzinga
Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization - TradingView — Track All Markets
Tempus AI, Inc. (TEM) Stock Analysis: Unpacking the 42.59% Potential Upside Amidst Healthcare Tech Revolution - DirectorsTalk Interviews
Artificial Intelligence Stocks To Follow NowJanuary 1st - MarketBeat
Tempus AI (TEM): Reassessing Valuation After Regulatory Pivot and Strengthening Diagnostics Position - simplywall.st
Tempus AI, Inc. Stock (TEM) Opinions on FDA Clearance and Price Drop - Quiver Quantitative
TD Cowen Reaffirms Hold Rating on Tempus AI (TEM), Cites the Company's Position to be a Leader - Finviz
Artificial Intelligence Stocks To ConsiderJanuary 2nd - MarketBeat
TD Cowen Reaffirms Hold Rating on Tempus AI (TEM), Cites the Company’s Position to be a Leader - Insider Monkey
Best Artificial Intelligence Stocks Worth WatchingDecember 31st - MarketBeat
Renaissance Capital LLC Buys 17,866 Shares of Tempus AI, Inc. $TEM - MarketBeat
Canaccord lowers price objective on Tempus AI, Inc. (TEM) - MSN
Finanzdaten der Tempus Ai Inc-Aktie (TEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.37%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):